Evidence map›Paper›PMID 34391589›Full record

ArticleJournal of substance abuse treatment2022

Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults.

Justine W Welsh, Michael L Dennis, Rodney Funk, Maggie J Mataczynski, Mark D Godley

Open access · greenAbstract read
In one paragraph

Article in Journal of substance abuse treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Emergency department management of opioid use disorder in pediatric patients.Journal of the American College of Emergency Physicians open · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Justine W WelshDepartment of Psychiatry and Behavioral Services, Emory University School of Medicine, 12 Executive Park Drive NE, Atlanta, GA 30329, USA. Electronic address: Justine.welsh@emory.edu.
Michael L DennisChestnut Health Systems, 448 Wylie Drive, Normal, IL 61716, USA.
Rodney FunkChestnut Health Systems, 448 Wylie Drive, Normal, IL 61716, USA.
Maggie J MataczynskiDepartment of Psychiatry and Behavioral Services, Emory University School of Medicine, 12 Executive Park Drive NE, Atlanta, GA 30329, USA.
Mark D GodleyChestnut Health Systems, 448 Wylie Drive, Normal, IL 61716, USA.
Chestnut Health Systems · USEmory University · US

Funding

Smartphone Addiction Recovery Coach for Young Adults (SARC-YA) ExperimentR01DA011323 · NIDA · CHESTNUT HEALTH SYSTEMS, INC. · PI MICHAEL L. DENNIS, ASHLI J SHEIDOW · 1999 to 2026
$5.5M
Evaluating the combination of the Adolescent Community Reinforcement Approach and medication-assisted treatment in young adults with severe opioid use disorderR21DA046738 · NIDA · EMORY UNIVERSITY · PI WELSH, JUSTINE WITTENAUER · 2018 to 2019
$390k
NIDA NIH HHS R01 DA011323NIDA NIH HHS R21 DA046738
6 · The paper itself

Abstract

backgroundTreatment of opioid use disorder (OUD) in adolescents and young adults is imperative to reduce the risk of overdose and other opioid-related harms. Limited information has been published about national trends in health disparities including utilization, access to medication for opioid use disorder (MOUD), and treatment retention of adolescents and young adults with OUD.

methodsThis secondary data analysis tested for trends and age-related disparities in national OUD treatment admissions, as well as length of stay (defined as continuous enrollment in some form of treatment at a program) and planned use of MOUD for adolescents (age 12-17) and young adults (age 18-24) using the Treatment Episode Data Set from 2008 to 2017. The study also used data from the National Survey on Drug Use and Health to identify population prevalence of OUD and presentation to OUD treatment in adolescents and young adults compared to older adults (age 25+).

resultsOUD treatment admissions significantly decreased over the decade by 63% (z = 2.61, p < .01) for adolescents and 13% (z = 2.25, p < .01) for young adults. The rate of planned MOUD at intake increased from 1.1% to 3.0% for adolescents but did not achieve significance. MOUD was more commonly recommended in young adults across the time period (13.5 to 21.8%, z = 2.24, p < .01). Treatment length of stay did not change significantly for adolescents, but did increase for young adults from 2008 to 2017 in the 91+ (19.9-23.9%, z = 2.22, p < .01) and 181+ days (9.7-12.5%, z = 2.26, p < .01) categories. Relative to older adults, the percent of people with OUD presenting for OUD treatment is significantly lower for adolescents (44.6% vs. 3.6%, OR = 0.05, p < .05) and young adults (44.6% vs. 22.2%, OR = 0.36, p < .05). Among those who initiated treatment, lower rates occurred of planned MOUD for adolescents (93% vs. 2%, OR = 0.002, p < .05) and young adults (93% vs. 56%, OR = 0.10, p < .05).

conclusionsA significant unmet need exists for OUD treatment and recommendation of MOUD in adolescents and young adults with OUD. These trends are concerning given increasing rates of opioid-related emergency room admissions and deaths during the same time period. Federal and state funders should examine adolescent and young adult's services separately from older adults (25+) to reduce age-related access disparities and ensure adequate MOUD treatment capacity.

Indexed as

BuprenorphineDrug OverdoseOpioid-Related DisordersAdolescentAdultAgedAnalgesics, OpioidChildHumansOpiate Substitution TreatmentYoung AdultAnalgesics, OpioidBuprenorphineAdolescentMedications for opioid use disorderOpioid use disorderTreatment admissionYoung adult

Identifiers

PMID34391589
PMCPMC8671231
OpenAlexW3190966577

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.